Biotest AG ST O.N (BIOG)

43.100
-0.100(-0.23%)
  • Volume:
    263
  • Bid/Ask:
    43.000/43.100
  • Day's Range:
    43.000 - 43.200
  • Type:Equity
  • Market:Germany
  • ISIN:DE0005227201
  • WKN:522720

BIOG Overview

Prev. Close
43.2
Day's Range
43-43.2
Revenue
514M
Open
43.2
52 wk Range
25.6-44.1
EPS
-0.75
Volume
263
Market Cap
1.71B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,713
P/E Ratio
-
Beta
0.38
1-Year Change
68.36%
Shares Outstanding
39,571,452
Next Earnings Date
28 Mar 2022
What is your sentiment on Biotest AG ST O.N?
or
Market is currently closed. Voting is open during market hours.

Biotest AG ST O.N Company Profile

Employees
1928
Market
Germany

Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in haematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company’s products also comprise Cytotect for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and IgG Next Genration for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, as well as neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B re-infection prophylaxis after liver transplantation. In addition, it provides Albiomin and Biseko to restore and maintain circulating blood volume; Cofact for the treatment of clotting factors deficiency; Fibrinogen to treat congenital and acquired fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; Anti-SARS-CoV-2 hyperimmunoglobulin for COVID-19 treatment; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. Biotest Aktiengesellschaft was founded in 1946 and is headquartered in Dreieich, Germany.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellSellStrong Buy
Technical IndicatorsBuyBuyBuyStrong SellStrong Buy
SummaryNeutralNeutralNeutralStrong SellStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.